Pangea Bio Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Pangea Bio is a biotechnology research company based in London, England. It focuses on developing therapies that directly activate the TrkB receptor to promote neuronal and synaptic plasticity and provide neuroprotection. By targeting the BDNF/TrkB signaling pathway, the company addresses mechanisms linked to conditions such as schizophrenia, depression, Alzheimer's disease, Parkinson's disease, and glaucoma. The organization operates as a small to mid-sized enterprise within the biotech research sector. Its work sits within neuroscience and biotech research, aiming at approaches that modify disease progression in neuropsychiatric and neurodegenerative disorders. In the broader biotech landscape, the company’s focus aligns with efforts to influence neurotrophic signaling and neuroprotection.